Early Involvement of Palliative Care in Cancer Treatment

Patients with cancer have many needs, often requiring a multidisciplinary approach to treat the disease. In addition to the treatment of disease with systemic or local anti-cancer therapies, most patients will have psychosocial, physical, social and spiritual symptoms that require addressing. The early involvement of palliative care can help address and treat these other aspects of cancer, improving the patient’s quality of life and, in some cases, outcomes. Too often, palliative care is instituted late in the disease trajectory, if at all, which can lead to unnecessary suffering on the part of patients and caregivers.

Target Audience

This program is designed to meet the educational needs of oncology nurses who manage patients with cancer. 

Learning Objectives

Following this activity, participants should be able to:

  • Discuss the importance of early referral to a multidisciplinary palliative care team.
  • Explain the role of the nurse/advanced practice provider in palliative care.
  • Describe how patients and health care systems can benefit from early palliative care.
Additional information
Supporters: 

This activity is supported by educational grants from Genentech, a member of the Roche Group; Novartis; and Seagen. This activity is supported by independent educational grants from Incyte Corporation and Merck & Co., Inc. This activity is supported by an independent medical educational grant from ADC Therapeutics. This activity is supported by a grant from Pfizer Inc.

Course summary
Available credit: 
  • 0.75 ANCC contact hours
    • 0.50 ANCC Pharmacology Contact Hours
  • 0.75 Participation
Course opens: 
05/15/2023
Course expires: 
03/01/2024
Cost:
$0.00

Carey Ramirez, ANP-C, ACHPN
City of Hope National Medical Center

 

NCCN Continuing Education Disclosure Policy

It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates, and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions 

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below have no relevant financial relationship(s) with ineligible companies to disclose.

Carey Ramirez, ANP-C, ACHPN 

NCCN Staff Disclosures 

None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses
NCCN designates this educational activity for a maximum of 0.75 contact hour, 0.50 of which are pharmacotherapeutic contact hours.

Available Credit

  • 0.75 ANCC contact hours
    • 0.50 ANCC Pharmacology Contact Hours
  • 0.75 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing